Reports

Sale

Assisted Reproductive Technology Market

Global Assisted Reproductive Technology Market Size, Share: By Procedure: Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking; By Age: Women Younger Than Age 35, Women Older Than Age 35; By Application; By End User; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global Assisted Reproductive Technology Market Outlook

The global assisted reproductive technology market size was valued at USD 14.4 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 20.9 billion by 2032.

 

Assisted Reproductive Technology: Introduction

ART (Assisted Reproductive Technology) refers to fertility treatments that involve handling either eggs or embryos. Typically, ART procedures entail surgically extracting eggs from a woman's ovaries, combining them with sperm in a laboratory, and then either transferring them back to the woman's body or donating them to another woman. However, ART procedures do not involve treatments that only handle sperm (such as artificial insemination) or those where a woman takes medication to stimulate egg production without retrieving the eggs.

 

assisted reproductive technology market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Assisted Reproductive Technology Market Analysis

The increasing advancements in the field by key players are expected to drive the market growth in the coming years. The expanding applications of AI in assisted reproductive technology (ART) is expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos, promoting healthy pregnancy, further propelling the global assisted reproduction technology market growth.

 

The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For example, The Ministry of Health and Family Welfare (MoHFW) has recently rolled back the manner of retrieving oocytes and placing embryos vide Assisted Reproductive Technology Regulations in a manner where the health of no one is compromised.

 

The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Companies are integrating AI to enhance the overall experience and outcomes from the procedure to create a great impact on people and the market. For example, Alife Health wanted to reduce the overall cost of care so that more people could afford the benefits. Increasing investments by companies are also poised to drive the assisted reproductive technology market growth further. For example, Alife Health received an investment worth USD 22 million in early 2023 with which the company launched its AI platform to support and enhance clinical decision-making for IVF patients throughout the process, including during ovarian stimulation and embryo grading.

 

Additionally, in 2024, Alife Health plans to release two patient products that focus on providing health equity in the IVF space by helping people regardless of where they seek treatment. Such developments, initiatives, and thoughtful product launches are the major factors expected to further drive the market growth.

 

Global Assisted Reproductive Technology Market Segmentations

 

assisted reproductive technology market by segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Procedure

  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking

 

Market Breakup by Age

  • Women Younger Than Age 35
  • Women Older Than Age 35

 

Market Breakup by Application

  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others

 

Market Breakup by End User

  • Hospitals
  • Fertility Clinics
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

assisted reproductive technology market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Assisted Reproductive Technology Market Overview

The market growth is significantly driven by factors such as the adoption of a sedentary lifestyle by people worldwide, which is resulting in several health issues related to reproduction. The adoption of unhealthy habits, such as eating unhealthy, smoking, and consuming alcohol are major factors responsible for such issues. Due to these health issues, people are looking towards healthcare assistance to find a solution to their problems. The medical sector is advancing rapidly and there are a few procedures available to assist such people. The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the global assisted reproductive technology market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Gamete Intrafallopian Transfer (GIFT), and Zygote Intrafallopian Transfer (ZIFT), among others.

 

Significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.

 

Global Assisted Reproductive Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • California Cryobank
  • Bloom Fertility Centre
  • Anecova
  • CooperSurgical
  • Merck KGaA
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Nidacon International AB
  • Celmatix Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Procedure
  • Age
  • Application
  • End User
  • Region
Breakup by Procedure
  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking
Breakup by Age
  • Women Younger Than Age 35
  • Women Older Than Age 35
Breakup by Application
  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others
Breakup by End User
  • Hospitals
  • Fertility Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • California Cryobank
  • Bloom Fertility Centre
  • Anecova
  • CooperSurgical
  • Merck KGaA
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Nidacon International AB
  • Celmatix Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Assisted Reproductive Technology Market Overview
 
    3.1    Global Assisted Reproductive Technology Market Historical Value (2017-2023) 
    3.2    Global Assisted Reproductive Technology Market Forecast Value (2024-2032)
4    Global Assisted Reproductive Technology Market Landscape
    4.1    Global Assisted Reproductive Technology: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Assisted Reproductive Technology: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Assisted Reproductive Technology Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Assisted Reproductive Technology Market Segmentation
    6.1    Global Assisted Reproductive Technology Market by Procedure
        6.1.1    Market Overview
        6.1.2    Fresh Donor
        6.1.3    Fresh Nondonor
        6.1.4    Frozen Donor
        6.1.5    Frozen Nondonor
        6.1.6    Embryo/Egg Banking
    6.2    Global Assisted Reproductive Technology Market by Age
        6.2.1    Market Overview
        6.2.2    Women Younger Than Age 35
        6.2.3    Women Older Than Age 35
    6.3    Global Assisted Reproductive Technology Market by Application
        6.3.1    Market Overview
        6.3.2    Artificial Insemination - Intrauterine Insemination (AI-IUI)
        6.3.3    Frozen Embryo Replacement (FER)
        6.3.4    Surrogacy
        6.3.5    Ovulation Induction
        6.3.6    Others
    6.4    Global Assisted Reproductive Technology Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Fertility Clinics
        6.4.4    Others
    6.5    Global Assisted Reproductive Technology Market by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Assisted Reproductive Technology Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Assisted Reproductive Technology Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Assisted Reproductive Technology Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Assisted Reproductive Technology Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Assisted Reproductive Technology Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    California Cryobank
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications 
    17.2    Bloom Fertility Centre
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Anecova
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    CooperSurgical
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Merck KGaA
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Ferring B.V.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    FUJIFILM Irvine Scientific
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Genea Limited
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Nidacon International AB
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Celmatix Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 14.4 billion in 2023, driven by the increasing adoption of a sedentary lifestyle.

The market is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 20.9 billion by 2032.

The increasing incidence of infertility among people due to genetic factors or a sedentary lifestyle is a major factor driving the market growth.

Rapidly advancing technological development and significantly increasing awareness about assisted reproductive technologies are among the major trends influencing the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

Women younger than age 35 and older than age 35 can benefit from this technology.

Assisted reproductive technology finds wide applications in Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), surrogacy, and ovulation induction, among others.

End users in the market are hospitals and fertility clinics, among others.

Key players involved in the market are California Cryobank, Bloom Fertility Centre, Anecova, CooperSurgical, Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Nidacon International AB, Celmatix Inc., and Merck KGaA.

Purchase Full Report

Mini Report

$ 3499     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 7999     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 9999     $5999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER